Cargando…
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy
[Image: see text] Synthetic lethality (SL) is an innovative strategy in targeted anticancer therapy that exploits tumor genetic vulnerabilities. This topic has come to the forefront in recent years, as witnessed by the increased number of publications since 2007. The first proof of concept for the e...
Autores principales: | Pismataro, Maria Chiara, Astolfi, Andrea, Barreca, Maria Letizia, Pacetti, Martina, Schenone, Silvia, Bandiera, Tiziano, Carbone, Anna, Massari, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226047/ https://www.ncbi.nlm.nih.gov/pubmed/37134182 http://dx.doi.org/10.1021/acs.jmedchem.2c02101 |
Ejemplares similares
-
Synthetic Lethality Targeting Polθ
por: Drzewiecka, Małgorzata, et al.
Publicado: (2022) -
Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
por: Zatreanu, Diana, et al.
Publicado: (2021) -
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia
por: Astolfi, Andrea, et al.
Publicado: (2022) -
Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours
por: Barszczewska-Pietraszek, Gabriela, et al.
Publicado: (2022) -
Q-raKtion:
A Semiautomated KNIME Workflow for
Bioactivity Data Points Curation
por: Palazzotti, Deborah, et al.
Publicado: (2022)